Skip to main content

Military Health System

Utility Navigation Links

WEEKEND MAINTENANCE: The maintenance outage is scheduled for June 22nd at 6:00am EST ending NLT Sunday, June 23rd at 11:59pm Eastern EST. The TRICARE Manuals web site may be available intermittently during this period but it's usage is not recommended.

TRICARE Policy Manual 6010.63-M, April 2021
Chapter 7
Section 2.6
Chelation Therapy
Issue Date:  October 12, 1984
Copyright:  CPT only © 2006 American Medical Association (or such other date of publication of CPT). All Rights Reserved.
Chelation techniques for the therapeutic or preventive effects of removing unwanted metal ions from the body.
Chelation therapy is covered if the chelator is United States (US) Food and Drug Administration (FDA) approved and the therapy is for an FDA approved indication.
Chelation therapy (or chemical endarterectomy) is considered an unproven therapeutic modality for the treatment of the following conditions, and is not covered:
•  Multiple Sclerosis (MS).
•  Arthritis.
•  Hypoglycemia.
•  Diabetes.
•  Arteriosclerosis.
•  Malaria.
•  Cancer.
•  Alzheimer’s disease.
•  Autism Spectrum Disorders (ASD).
•  Other off-label uses of FDA approved chelating agents.
- END -
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery